GlassScriptPhysician profile
Terrence W Bruner
NPI 1588803530
$2,148.26
in general payments reported to CMS, 2019-2025
49 companies · $510 in 2025
The $510 reported for 2025 was more than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $242 · 2020: $76.04 · 2021: $276 · 2022: $306 · 2023: $320 · 2024: $417 · 2025: $510.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,247.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,247.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $201.42 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $115.20 | 2019-2025 | Calquence, Tagrisso |
| Tela Bio, INC. | $110.75 | 2024-2025 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Mentor Worldwide LLC | $104.53 | 2023-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Abbvie INC. | $91.90 | 2023-2025 | Natrelle Saline-Filled Breast Implants, Botox |
| Merck Sharp & Dohme LLC | $88.66 | 2021-2025 | Keytruda |
| Seagen INC. | $85.26 | 2019-2023 | Padcev |
| Sientra, INC. | $75.07 | 2021 | |
| Celgene Corporation | $72.07 | 2019-2025 | Reblozyl |
| Jazz Pharmaceuticals INC. | $71.35 | 2021-2023 | |
| Novartis Pharmaceuticals Corporation | $68.30 | 2019-2021 | |
| Janssen Biotech, INC. | $65.50 | 2019-2025 | Erleada |
| Amgen INC. | $62.13 | 2019-2022 | |
| Incyte Corporation | $56.48 | 2020-2025 | Monjuvi, Zynyz |
| Musculoskeletal Transplant Foundation INC. | $54.79 | 2025 |
Show all 49 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Terrence Bruner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.